In this issue: Phoenix Closes on Bargain Purchase of Chrysalis, New Sudy Claims CROs Speed Phase III Clinical Trials bu 30%, Quarterly Reports, PPD Pharmaco Changes Name to PPD Development, CenterWatch Publishes New Edition of Source Book, The CenterWatch Index, Industry Briefs, Drug Pipeline News, Trial Results and Personnel